Cancer Drugs That Free Brake on Immune System Show Promise for Hodgkin’s
Sunday, December 7, 2014 - 01:10
in Health & Medicine
In two early stage studies, Bristol-Myers Squibb’s nivolumab and Merck’s pembrolizumab shrank tumors in patients with Hodgkin’s lymphoma.
